GGrantIndex
← Search

PHASE I/II TRIAL OF CPT-11 AND TEMOZOLOMIDE IN RECURRENT MALIGNANT GLIOMA

$931M01FY2006RRNIH

University Of Wisconsin-Madison, Madison WI

Investigators

Linked publications & trials

View original record on NIH RePORTER →